Generic Competition Pushing Down HIV Drug Prices, But Patents Keep Newer Drugs Unaffordable
MSF Pricing Analysis Also Extends to HIV Diagnostic and Monitoring Tools
- See more at: http://www.doctorswithoutborders.org/press/release.cfm?id=6844&cat=press-release#sthash.mXd4nRe0.dpuf
http://www.doctorswithoutborders.org/press/release.cfm?id=6844&cat=press-release
